Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised staging system for NKTCL.

Both monotherapy and combination therapy containing epcoritamab had high response rates and survival benefits when compared ...

Follicular lymphoma is a diverse disease ... The general approach should be a combination of rituximab and chemotherapy, traditionally using alkylating agents, with or without an anthracycline ...